Cargando…
AF1q inhibited T cell attachment to breast cancer cell by attenuating Intracellular Adhesion Molecule-1 expression
AIM: To investigate whether AF1q, overexpressed in metastatic cells compared with the primary tumor cells, plays a pivotal role in breast cancer metastasis. METHODS: To investigate whether AF1q has a responsibility in the acquisition of a metastatic phenotype, we performed RNA-sequencing (RNA-Seq) t...
Autores principales: | Park, Jino, Hwang, Jae Yeon, Thore, Alexandra, Kim, Soojin, Togano, Tomiteru, Hagiwara, Shotaro, Park, Juw Won, Tse, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6623974/ https://www.ncbi.nlm.nih.gov/pubmed/31297450 http://dx.doi.org/10.20517/2394-4722.2018.84 |
Ejemplares similares
-
MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling
por: Park, Jino, et al.
Publicado: (2016) -
AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis
por: Park, Jino, et al.
Publicado: (2015) -
Bortezomib-thalidomide-dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide as a Salvage and Bridging Regimen before Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma
por: Togano, Tomiteru, et al.
Publicado: (2022) -
Involvement of AF1q/MLLT11 in the progression of ovarian cancer
por: Tiberio, Paola, et al.
Publicado: (2017) -
Intracellular Adhesion Molecule‐1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8(+) T Cells
por: Lee, Se‐Hoon, et al.
Publicado: (2023)